The study is aimed at evaluating an injection device with participants with Rheumatoid Arthritis. The device will not contain a needle or real drug, and the testing will involve simulating use of the device. The output of the study will inform the development of a solution that meets the needs of end-users and this is where they need you. The study will involve a 60-minute on-site interview. There are various study locations available across the UK from the 7th to the 27th June. Participants will be paid for their time involved in the testing. The process is being managed by Crux Product Design, a Bristol-based design consultancy specialising in medical device development on behalf of a client.
To meet the recruitment criteria, you must be diagnosed with RA, have hand dexterity impairments and be over the age of 18. No experience with injection devices is needed. If you are interested in taking part in this study, or would like to find out more about it, please email research@cruxproductdesign.com.
Written by
Aribah-NRAS
Partner
To view profiles and participate in discussions please or .
Your message couldn't be delivered. The Domain Name System (DNS) reported that the recipient's domain does not exist.
Contact the recipient by some other means (by phone, for example) and ask them to tell their email admin that it appears that their domain isn't properly registered at their domain registrar. Give them the error details shown below. It's likely that the recipient's email admin is the only one who can fix this problem.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.